|
HNRNPF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.663660E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.011700E-04 |
| Normal-vs-Stage2 |
3.067600E-02 |
| Normal-vs-Stage3 |
9.502200E-01 |
| Normal-vs-Stage4 |
7.368600E-01 |
| Stage1-vs-Stage2 |
6.204000E-01 |
| Stage1-vs-Stage3 |
1.333940E-02 |
| Stage1-vs-Stage4 |
5.105900E-02 |
| Stage2-vs-Stage3 |
1.442800E-01 |
| Stage2-vs-Stage4 |
1.180650E-01 |
| Stage3-vs-Stage4 |
7.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.604500E-04 |
| Normal-vs-AfricanAmerican |
1.387940E-02 |
| Normal-vs-Asian |
6.050000E-01 |
| Caucasian-vs-AfricanAmerican |
7.701400E-01 |
| Caucasian-vs-Asian |
2.857800E-01 |
| AfricanAmerican-vs-Asian |
3.128400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.66130000000587E-05 |
| Normal-vs-Female |
7.471200E-01 |
| Male-vs-Female |
4.136200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.695760E-03 |
| Normal-vs-Extreme_Weight |
1.120100E-03 |
| Normal-vs-Obese |
1.247560E-01 |
| Normal-vs-Extreme_Obese |
8.227800E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.884000E-01 |
| Normal_Weight-vs-Obese |
1.163990E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.881600E-01 |
| Extreme_Weight-vs-Obese |
1.186610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.013000E-01 |
| Obese-vs-Extreme_Obese |
9.194200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.170800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.819900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.84139999999511E-05 |
| Normal-vs-Age(81-100Yrs) |
1.996090E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.025930E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.823800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.184400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.448400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.698000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.417000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.803700E-04 |
| Normal-VS-Type2 PRCC |
4.372100E-04 |
| Normal-VS-KIRP CIMP |
3.955800E-03 |
| Normal-VS-Unclassified PRCC |
1.006200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.275800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.390500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.901200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.175660E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.431000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.722700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.08840000000588E-05 |
| Normal-vs-N1 |
1.108610E-01 |
| Normal-vs-N2 |
4.512200E-01 |
| N0-vs-N1 |
2.840000E-04 |
| N0-vs-N2 |
3.033000E-01 |
| N1-vs-N2 |
2.891400E-01 |
|
|
